Showing results (4901-4910 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|December 28, 2020
Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancerTyler R McCaw, Nidhi Goel, Dewey J Brooke, et al.Cancer Medicine|December 31, 2020
Circulating CEA-positive and EpCAM-negative tumor cells might be a predictive biomarker for recurrence in patients with gastric cancerYuichiro Miki, Masakazu Yashiro, Kenji Kuroda, et al.Cancer Medicine|December 19, 2020
Metabolic response as assessed by 18 F-fluorodeoxyglucose positron emission tomography-computed tomography does not predict outcome in patients with intermediate- or high-risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeDouglas J Harrison, Yueh-Yun Chi, Jing Tian, et al.Cancer Medicine|December 22, 2020
Artificial neural networks for simultaneously predicting the risk of multiple co-occurring symptoms among patients with cancerWenhui Xuyi, Hsien Seow, Rinku SutradharCancer Medicine|September 18, 2020
Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer PatientsDouglas Tremblay, Carina Seah, Thomas Schneider, et al.Cancer Medicine|January 1, 2020
Significance of concurrent use of weekly cisplatin in carbon-ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix: A propensity score-matched analysisNoriyuki Okonogi, Masaru Wakatsuki, Shingo Kato, et al.Cancer Medicine|January 12, 2020
Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohortXue-Song Sun, Bei-Bei Xiao, Chao Lin, et al.Cancer Medicine|January 4, 2020
Developing a cancer-specific trigger tool to identify treatment-related adverse events using administrative dataSaul N Weingart, Jason Nelson, Benjamin Koethe, et al.Cancer Medicine|December 26, 2019
The association between DXA-derived body fat measures and breast cancer risk among postmenopausal women in the Women's Health InitiativeRhonda S Arthur, Xiaonan Xue, Victor Kamensky, et al.Cancer Medicine|December 19, 2019
98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemiaKe Shi, Qian Sun, Chun Qiao, et al.Pageof 935